Eight mongoloid male patients, ranging in age from 5 to 9 yr., were treated with an oral anabolic steroid Wyeth) in the course of metabolic investigations only remotely con¬ nected with the dermatitis. A remarkable improvement in the skin condition was noticed. In order to check the validity of this observation, four mongoloid patients were selected in addition to the eight already on treatment to match the previous group with regard to age and sex. Their skin showed the typical 'mongoloid der¬ matitis ' with various degrees of severity. They were treated for 42 days and received an average of 90 mg. of the steroid during this period. The daily dose varied between 1-25 and 2-25 mg., depending on the patients' ages and their response to the treatment.
Eight mongoloid male patients, ranging in age from 5 to 9 yr., were treated with an oral anabolic steroid (DL-13/?-ethyl-17-hydroxy-18:19-dinor-17a-pregn-4-en-3-one, Wyeth) (Received 27 January 1964) Fig. 1 . Patient L.R., aged 9 years. Acute exacerbation of a long-standing dermatitis of the feet. Fig. 2 . The same patient after 18 days of treatment with Dl-13/?-ethyl-17-hydroxy-18:19-dinor-17a-pregn-4-en-3-one. Fig. 3 . The same patient after 36 days of treatment.
